GeneDx Holdings Corp. logo WGS - GeneDx Holdings Corp.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY 0
BUY 10
HOLD 1
SELL 0
STRONG
SELL 0
| PRICE TARGET: $87.43 DETAILS
HIGH: $150.00
LOW: $63.00
MEDIAN: $75.00
CONSENSUS: $87.43
UPSIDE: 41.43%

Stock News

Robbins LLP Reminds WGS Investors of the Pending Class Action Lawsuit; Harmed Investors Should Contact the Firm for Information About Leading the Class Action Against GeneDx Holdings Corp.

Robbins LLP Reminds WGS Investors of the Pending Class Action Lawsuit; Harmed Investors Should Contact the Firm for Information About Leading the Class Action Against GeneDx Holdings Corp.

SAN DIEGO, July 22, 2026 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired GeneDx Holdings Corp. (NASDAQ: WGS) common stock between April 16, 2025 and May 4, 2026. GeneDx Holdings Corp is a genomics company that provides genetic testing services for diagnosing pediatric and rare diseases.

Jul 22, 2026 06:30 AM • globenewswire.com (Hide legal announcements)
Robbins LLP Reminds WGS Investors of the Pending Class Action Lawsuit; Harmed Investors Should Contact the Firm for Information About Leading the Class Action Against GeneDx Holdings Corp.

Robbins LLP Reminds WGS Investors of the Pending Class Action Lawsuit; Harmed Investors Should Contact the Firm for Information About Leading the Class Action Against GeneDx Holdings Corp.

SAN DIEGO, July 22, 2026 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired GeneDx Holdings Corp. (NASDAQ: WGS) common stock between April 16, 2025 and May 4, 2026. GeneDx Holdings Corp is a genomics company that provides genetic testing services for diagnosing pediatric and rare diseases.

Jul 22, 2026 06:30 AM • globenewswire.com (Hide legal announcements)
WGS Deadline Alert: Levi & Korsinsky Reminds GeneDx Holdings Corp. (WGS) Investors of Securities Class Action Deadline on August 3, 2026

WGS Deadline Alert: Levi & Korsinsky Reminds GeneDx Holdings Corp. (WGS) Investors of Securities Class Action Deadline on August 3, 2026

The Red Flags: What GeneDx Insiders Allegedly Knew About Fabric Genomics' Failures Before Shareholders Learned the $31.2 Million Truth NEW YORK, July 22, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP announces that a securities class action has been filed against GeneDx Holdings Corp. (NASDAQ: WGS). YOU MAY BE AFFECTED IF YOU: Purchased WGS stock between April 16, 2025 and May 4, 2026 Lost money on your GeneDx investment Submit your information to recover losses or contact Joseph E.

Jul 22, 2026 06:09 AM • prnewswire.com (Hide legal announcements)
GeneDx Holdings Securities Fraud Class Action Result of Acquisition Performance Misrepresentations and 49% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

GeneDx Holdings Securities Fraud Class Action Result of Acquisition Performance Misrepresentations and 49% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

NEW YORK CITY and NEW ORLEANS, July 21, 2026 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until August 3, 2026 to file lead plaintiff applications in a securities class action lawsuit against GeneDx Holdings Corp. (NasdaqGS: WGS) (“GeneDx” or the “Company”), if they purchased or otherwise acquired the Company's shares between April 16, 2025 and May 4, 2026, inclusive (the “Class Period”).

Jul 21, 2026 06:24 PM • globenewswire.com (Hide legal announcements)
WGS INVESTOR DEADLINE: GeneDx Holdings Investors with Substantial Losses Have Opportunity to Lead the GeneDx Class Action Lawsuit- Hagens Berman

WGS INVESTOR DEADLINE: GeneDx Holdings Investors with Substantial Losses Have Opportunity to Lead the GeneDx Class Action Lawsuit- Hagens Berman

SAN FRANCISCO, July 21, 2026 /PRNewswire/ -- Hagens Berman (HBSS), a national leader in securities litigation, is actively investigating claims in a securities class action lawsuit against GeneDx Holdings (NASDAQ: WGS) and its executives, alleging defendants misled investors about the Fabric Genomics acquisition and synergy potential. The suit follows a devastating 49% stock collapse on May 5, 2026 in response to the company's disastrous Q1 2026 earnings report, including a $31.2 million impairment charge.

Jul 21, 2026 12:02 PM • prnewswire.com (Hide legal announcements)
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in GeneDx Holdings Corp. of Class Action Lawsuit and Upcoming Deadlines – WGS

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in GeneDx Holdings Corp. of Class Action Lawsuit and Upcoming Deadlines – WGS

NEW YORK, July 21, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against GeneDx Holdings Corp. (“GeneDx” or the “Company”) (NASDAQ: WGS).   Such investors are advised to contact Danielle Peyton at  [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

Jul 21, 2026 08:55 AM • globenewswire.com (Hide legal announcements)
ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages GeneDx Holdings Corp. Investors to Secure Counsel Before Important August 3 Deadline in Securities Class Action - WGS

ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages GeneDx Holdings Corp. Investors to Secure Counsel Before Important August 3 Deadline in Securities Class Action - WGS

New York, New York--(Newsfile Corp. - July 21, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of GeneDx Holdings Corp. (NASDAQ: WGS) between April 16, 2025 and May 4, 2026, inclusive (the "Class Period"), of the important August 3, 2026 lead plaintiff deadline. SO WHAT: If you purchased GeneDx common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

Jul 21, 2026 08:15 AM • newsfilecorp.com (Hide legal announcements)
Bronstein, Gewirtz & Grossman LLC Urges GeneDx Holdings Corp. Investors to Act: Class Action Filed Alleging Investor Harm

Bronstein, Gewirtz & Grossman LLC Urges GeneDx Holdings Corp. Investors to Act: Class Action Filed Alleging Investor Harm

New York, New York--(Newsfile Corp. - July 21, 2026) - Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against GeneDx Holdings Corp. (NASDAQ: WGS) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired GeneDx securities between April 16, 2025 and May 4, 2026, both dates inclusive (the "Class Period").

Jul 21, 2026 08:00 AM • newsfilecorp.com (Hide legal announcements)
Portnoy Law Firm Announces Class Action on Behalf of GeneDX Holdings, Corp. Investors

Portnoy Law Firm Announces Class Action on Behalf of GeneDX Holdings, Corp. Investors

LOS ANGELES, July 21, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises GeneDX Holdings, Corp., (“GeneDX” or the "Company") (NASDAQ: WGS) investors of a class action on behalf of investors that bought securities between April 16, 2025 and May 4, 2026, inclusive (the “Class Period”). GeneDX investors have until August 3, 2026 to file a lead plaintiff motion.

Jul 21, 2026 06:27 AM • globenewswire.com (Hide legal announcements)
WGS UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds GeneDx (WGS) Investors of Securities Class Action Lawsuit Deadline on August 3, 2026

WGS UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds GeneDx (WGS) Investors of Securities Class Action Lawsuit Deadline on August 3, 2026

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In GeneDx To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in GeneDx between April 16, 2025 and May 4, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] New York, New York--(Newsfile Corp. - July 21, 2026) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against GeneDx Holdings Corp. ("GeneDx" or the "Company") (NASDAQ: WGS) and reminds investors of the August 3, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

Jul 21, 2026 04:25 AM • newsfilecorp.com (Hide legal announcements)
WGS DEADLINE ALERT: GeneDx Holdings Corp. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - August 3, 2026 Deadline

WGS DEADLINE ALERT: GeneDx Holdings Corp. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - August 3, 2026 Deadline

San Diego, California--(Newsfile Corp. - July 21, 2026) - Robbins Geller Rudman & Dowd LLP announces that purchasers of GeneDx Holdings Corp. (NASDAQ: WGS) common stock between April 16, 2025 and May 4, 2026, both dates inclusive (the "Class Period"), have until Monday, August 3, 2026 to seek appointment as lead plaintiff of the GeneDx class action lawsuit. Captioned Basma v.

Jul 21, 2026 03:35 AM • newsfilecorp.com (Hide legal announcements)
GeneDx Holdings Securities Fraud Class Action Result of Acquisition Performance Misrepresentations and 49% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

GeneDx Holdings Securities Fraud Class Action Result of Acquisition Performance Misrepresentations and 49% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

New York, New York and New Orleans, Louisiana--(Newsfile Corp. - July 20, 2026) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until August 3, 2026 to file lead plaintiff applications in a securities class action lawsuit against GeneDx Holdings Corp. (NASDAQ: WGS) ("GeneDx" or the "Company"), if they purchased or otherwise acquired the Company's shares between April 16, 2025 and May 4, 2026, inclusive (the "Class Period").

Jul 20, 2026 11:47 AM • newsfilecorp.com (Hide legal announcements)
WGS DEADLINE: ROSEN, A LEADING AND LONGSTANDING FIRM, Encourages GeneDx Holdings Corp. Investors to Secure Counsel Before Important Deadline in Securities Class Action - WGS

WGS DEADLINE: ROSEN, A LEADING AND LONGSTANDING FIRM, Encourages GeneDx Holdings Corp. Investors to Secure Counsel Before Important Deadline in Securities Class Action - WGS

NEW YORK, July 20, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of GeneDx Holdings Corp. (NASDAQ: WGS) between April 16, 2025 and May 4, 2026, inclusive (the “Class Period”), of the important August 3, 2026 lead plaintiff deadline.

Jul 20, 2026 11:27 AM • globenewswire.com (Hide legal announcements)
WGS Investors Have Opportunity to Lead GeneDx Holdings Corp. Securities Fraud Lawsuit with the Schall Law Firm

WGS Investors Have Opportunity to Lead GeneDx Holdings Corp. Securities Fraud Lawsuit with the Schall Law Firm

LOS ANGELES, July 20, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against GeneDx Holdings Corp. (“GeneDx” or “the Company”) (NASDAQ: WGS) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between April 16, 2025 and May 4, 2026, inclusive (the “Class Period”), are encouraged to contact the firm before August 3, 2026.

Jul 20, 2026 08:52 AM • globenewswire.com (Hide legal announcements)
HBSS Investigates Claims Against GeneDx Holdings (WGS) in Securities Class Action Suit Following Massive Impairment Charge

HBSS Investigates Claims Against GeneDx Holdings (WGS) in Securities Class Action Suit Following Massive Impairment Charge

SAN FRANCISCO, July 20, 2026 (GLOBE NEWSWIRE) -- Hagens Berman (HBSS), a national leader in securities litigation, is actively investigating claims in a securities class action lawsuit against GeneDx Holdings (NASDAQ: WGS) and its executives, alleging defendants misled investors about the Fabric Genomics acquisition and synergy potential. The suit follows a devastating 49% stock collapse on May 5, 2026 in response to the company's disastrous Q1 2026 earnings report, including a $31.2 million impairment charge.

Jul 20, 2026 05:29 AM • globenewswire.com (Hide legal announcements)
WGS DEADLINE: ROSEN, HIGHLY RECOGNIZED INVESTOR COUNSEL, Encourages GeneDx Holdings Corp. Investors to Secure Counsel Before Important Deadline in Securities Class Action - WGS

WGS DEADLINE: ROSEN, HIGHLY RECOGNIZED INVESTOR COUNSEL, Encourages GeneDx Holdings Corp. Investors to Secure Counsel Before Important Deadline in Securities Class Action - WGS

New York, New York--(Newsfile Corp. - July 19, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of GeneDx Holdings Corp. (NASDAQ: WGS) between April 16, 2025 and May 4, 2026, inclusive (the "Class Period"), of the important August 3, 2026 lead plaintiff deadline. SO WHAT: If you purchased GeneDx common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

Jul 19, 2026 07:07 PM • newsfilecorp.com (Hide legal announcements)

Price Targets